Molecular Dynamics Simulations in Designing DARPins as Phosphorylation-Specific Protein Binders of ERK2

Area of Science:

• Molecular Biology
• Biochemistry
• Drug Discovery

Background:

• Extracellular signal-regulated kinases 1 and 2 (ERK1/2) are crucial for cell survival and proliferation.
• Inhibitors targeting the ERK pathway show antitumor activity but face acquired drug resistance due to ERK1/2 reactivation.
• Designed ankyrin repeat proteins (DARPins) offer a novel approach for targeted protein inhibition.

Purpose of the Study:

• To develop novel DARPin macromolecules as inhibitors targeting ERK2.
• To elucidate the structural basis of ERK2-DARPin interactions using molecular dynamics (MD) simulations.
• To predict and validate stabilizing mutations for enhanced DARPin efficacy.

Main Methods:

• Molecular dynamics (MD) simulations to study ERK2-DARPin interactions.
• MAESTRO web-based algorithm for predicting stabilizing mutations.
• All-atom, explicit-solvent MD simulations to evaluate mutation performance.

Main Results:

• Identified specific mutations (Ala → Asp and Ser → Leu) that improve DARPin performance.
• Analysis revealed enhanced stability and key residue interactions for the mutated DARPins.
• MD simulations confirmed the predictive accuracy of the design strategies.

Conclusions:

• DARPins represent a promising class of inhibitors targeting ERK2.
• Computational design strategies, including MD simulations and mutation prediction, are effective for developing improved protein inhibitors.
• These findings offer a potential strategy to overcome resistance to existing MAPK inhibitors in cancer therapy.